Steven M Bair

6PUBLICATIONS
39CO-AUTHORS
Liquid biopsiesHaematological tumoursHaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 18, 2026
TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.

|Jun 09, 2026
Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamab.

|Feb 20, 2020
Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy.

Steven M Bair, Joshua D Brandstadter, Emily C Ayers

|Mar 13, 2019
Accelerating chimeric antigen receptor therapy in chronic lymphocytic leukemia: The development and challenges of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia.

Steven M Bair, David L Porter

|Dec 21, 2018
Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis.

Steven M Bair, Lauren E Strelec, Tatyana A Feldman

|May 18, 2017
Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis.

Steven M Bair, Lauren Strelec, Sarah J Nagle

Pageof 1

Frequent Collaborators

2 joint publications

Allison M Bock

1 joint publications

Cassandra Duarte

1 joint publications

Grace N Bosma

1 joint publications

Diana Abbott